A prospective, open, randomized, phase-II study of a therapeutic cancer vaccine (L-BLP25, Stimuvax) in the pre-operative treatment of women with primary breast cancer.
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Tecemotide (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Letrozole
- Indications Early breast cancer
- Focus Therapeutic Use
- 12 Sep 2017 Results (n=385) of quality-of-life analysis, presented at the 42nd European Society for Medical Oncology Congress.
- 23 May 2017 Status changed from recruiting to completed.
- 02 Apr 2012 New trial record